Eli Lilly CEO Cites Growth Beyond Weight Loss In Oncology, Immunology As Key To FY 2026 Outlook Raise – LLY Stock Surges To Record High In Pre-Market - Yahoo Finance

Source: Yahoo Finance ·

Eli Lilly CEO Cites Growth Beyond Weight Loss In Oncology, Immunology As Key To FY 2026 Outlook Raise – LLY Stock Surges To Record High In Pre-Market Yahoo Finance

BestAIBroker analysis

Read the original source